Table 2 Numeric and percentage distribution of the clinical variables of the participants regarding diabetes and COVID-19 (n = 1633)
Total | Type 1 diabetes | Type 2 diabetes | Other types | P value* | |||||
|---|---|---|---|---|---|---|---|---|---|
n = 1633 | % | n = 805 | % | n = 628 | % | n = 200 | % | ||
Time of diabetes diagnosis (years) | |||||||||
< 1 | 113 | 6.9 | 27 | 3.3 | 51 | 8.1 | 35 | 17.5 | |
1–10 | 667 | 40.9 | 209 | 26.0 | 372 | 59.2 | 86 | 43.0 | |
11–20 | 472 | 28.9 | 288 | 35.8 | 147 | 23.4 | 37 | 18.5 | |
≥ 21 | 356 | 21.8 | 280 | 34.8 | 58 | 9.2 | 18 | 9.0 | |
Not informed | 25 | 1.5 | 1 | 0.1 | – | – | 24 | 12.0 | |
Medical/clinical diagnosis of COVID-19 | 135 | 8.3 | 64 | 7.9 | 58 | 9.2 | 13 | 6.5 | < 0.0001 |
Testing for COVID-19 | 437 | 26.8 | 219 | 27.2 | 172 | 27.4 | 46 | 23.0 | < 0.0001 |
Test result for COVID-19 (n = 437) | < 0.0001 | ||||||||
Positive | 120 | 25.8 | 57 | 25.8 | 52 | 29.7 | 11 | 15.7 | |
Negative | 310 | 66.5 | 157 | 71.0 | 119 | 68.0 | 34 | 48.6 | |
No result received | 7 | 1.5 | 5 | 2.3 | 1 | 0.6 | 1 | 1,4 | |
Hospitalization due to COVID-19 (n = 140) | 42 | 30.0 | 19 | 28.8 | 23 | 37.7 | – | – | |